SCHEMBL6162716

SCHEMBL6162716

CN1CCN(c2ccc(Cc3ccc(F)cc3)cc2)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.61
TP53 P04637 2/20 0.61
NPC1 O15118 1/20 0.61
RAB9A P51151 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
NCF1 P14598 1/20 0.55
CHKA P35790 2/20 0.54
HTR6 P50406 2/20 0.54
MAPT P10636 3/20 0.53
ALDH1A1 P00352 3/20 0.52
GFER P55789 2/20 0.52
KMT2A Q03164 2/20 0.52
KDM4E B2RXH2 2/20 0.52
MAPK1 P28482 1/20 0.52
HTT P42858 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
GAA P10253 1/20 0.52
ADRA2C P18825 1/20 0.52
PTK2B Q14289 1/20 0.52
ESR2 Q92731 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1375430 0.89 LMNA (0.73) LMNATP53NPC1RAB9ASMN1; SMN2
SCHEMBL7582559 0.84 NCF1 (0.57) NPC1RAB9ANCF1CHKAHTR6
SCHEMBL8577561 0.81 NPC1 (0.59) LMNATP53NPC1RAB9ASMN1; SMN2
SCHEMBL25802996 0.81 LMNA (0.65) LMNATP53NPC1RAB9ASMN1; SMN2
SCHEMBL3063745 0.81 GAA (0.70) LMNATP53NPC1RAB9ASMN1; SMN2
SCHEMBL7961519 0.81 SMN1; SMN2 (0.56) LMNATP53SMN1; SMN2NCF1CHKA
SCHEMBL27847240 0.80 NCF1 (0.48) LMNASMN1; SMN2NCF1CHKAMAPT
SCHEMBL12826299 0.79 MAPT (0.64) LMNATP53NPC1RAB9ASMN1; SMN2
SCHEMBL3045378 0.79 ADRB1 (0.52) LMNATP53NCF1HTR6MAPT
SCHEMBL10373626 0.78 MAPT (0.77) LMNATP53NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0755923-B1 Ameliorant or remedy for symptoms caused by Ischemic diseases and Phenylpiperidine compounds useful therefor DAIICHI SUNTORY PHARMA CO LTD (JP) 2005-05-04 EP disclosed
US-6469010-B1 COMPOSITION ALSO FOR ALLEVIATION OR TREATMENT OF SYMPTOMS DERIVED FROM SEIZURES, EPILEPSY AND MIGRAINE HEADACHES, AND SUPPRESSION OF CALCIUM ION OVERLOAD SUNTORY LIMITED (JP) 2002-10-22 US disclosed
US-6048876-A ANTICONVULSANTS; ANTIEPILEPIC AGENT SUNTORY LIMITED (JP) 2000-04-11 US disclosed
EP-0755923-A1 AMELIORANT OR REMEDY FOR SYMPTOMS CAUSED BY ISCHEMIC DISEASES AND COMPOUNDS USEFUL THEREFOR SUNTORY LIMITED (JP) 1997-01-29 EP disclosed